A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.
NCT01929421 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2018-05-11
Summary
To assess the efficacy and safety of salvage tratment with Gemcitabine and S-1 Combination in metastatic colorectal cancer
Conditions
- Advanced Colorectal Cancer
Interventions
- DRUG
-
Gemcitabine/S-1
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2013-06-30
- Completion
- 2014-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer
NCT02618356 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
NCT07343791 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME
NCT02406118 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases
NCT06124729 ·Status: NOT_YET_RECRUITING
-
MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
NCT03400657 ·Status: UNKNOWN
-
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
NCT05353582 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy Study of Robotic Surgery for Rectal Cancer
NCT01591798 ·Status: UNKNOWN ·Phase: PHASE2
-
Multicenter Cross Sectional Study of Primary Intestine Lymphoma
NCT01043302 ·Status: COMPLETED
-
Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases
NCT06504901 ·Status: NOT_YET_RECRUITING
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
NCT06346093 ·Status: RECRUITING ·Phase: NA
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
NCT05914389 ·Status: RECRUITING ·Phase: PHASE2
-
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
NCT07309289 ·Status: RECRUITING ·Phase: PHASE3
-
Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection
NCT03123042 ·Status: COMPLETED ·Phase: NA
-
Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
NCT06848842 ·Status: RECRUITING ·Phase: PHASE2
-
The Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision
NCT01938027 ·Status: COMPLETED ·Phase: NA
-
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
NCT06002789 ·Status: RECRUITING ·Phase: PHASE2
-
Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer
NCT03098108 ·Status: UNKNOWN ·Phase: NA
-
The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer
NCT02425930 ·Status: COMPLETED
-
Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases
NCT02421432 ·Status: UNKNOWN ·Phase: NA
-
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）
NCT05781074 ·Status: RECRUITING ·Phase: PHASE2
-
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
NCT06120127 ·Status: RECRUITING ·Phase: PHASE2